| http://dbpedia.org/ontology/abstract
|
4-Morfolino-2,2-difenylomaślan etylu – org … 4-Morfolino-2,2-difenylomaślan etylu – organiczny związek chemiczny, syntetyczny opioid objęty Jednolitą konwencją o środkach odurzających z 1961 roku (wykaz I) pod nazwą dioxaphetyl butyrate (maślan dioksafetylu). W Polsce znajduje się w kategorii I-N wykazu środków odurzających i substancji psychotropowych, zatem jego posiadanie jest nielegalne.ch, zatem jego posiadanie jest nielegalne.
, Dioxaphetyl butyrate (INN; trade names Ami … Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol. It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea. In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregate manufacturing quota of zero.ual aggregate manufacturing quota of zero.
, Dioxafetylbutyrat, summaformel C22H27NO3, … Dioxafetylbutyrat, summaformel C22H27NO3, är ett smärtstillande och kramplösande preparat som tillhör gruppen opioider. Preparatet används inte som läkemedel i Sverige. Substansen är narkotikaklassad och ingår i förteckningen N I i 1961 års allmänna narkotikakonvention, samt i förteckning II i Sverige.nvention, samt i förteckning II i Sverige.
|
| http://dbpedia.org/ontology/casNumber
|
467-86-7
|
| http://dbpedia.org/ontology/fdaUniiCode
|
G751H98FY4
|
| http://dbpedia.org/ontology/pubchem
|
48194
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Spasmoxal.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
13951600
|
| http://dbpedia.org/ontology/wikiPageLength
|
3050
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1082990781
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Synthetic_opioids +
, http://dbpedia.org/resource/Lefetamine +
, http://dbpedia.org/resource/Category:Morpholines +
, http://dbpedia.org/resource/Analgesic +
, http://dbpedia.org/resource/Substance_dependence +
, http://dbpedia.org/resource/Dizziness +
, http://dbpedia.org/resource/Levacetylmethadol +
, http://dbpedia.org/resource/Category:Mu-opioid_receptor_agonists +
, http://dbpedia.org/resource/Category:Butyrate_esters +
, http://dbpedia.org/resource/Dextropropoxyphene +
, http://dbpedia.org/resource/Nausea +
, http://dbpedia.org/resource/Analgesia +
, http://dbpedia.org/resource/Category:Ethyl_esters +
, http://dbpedia.org/resource/Euphoria +
, http://dbpedia.org/resource/Sedation +
, http://dbpedia.org/resource/Opioid +
, http://dbpedia.org/resource/Constipation +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Dimenoxadol +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
22
|
| http://dbpedia.org/property/casNumber
|
467
|
| http://dbpedia.org/property/chemspiderid
|
43838
|
| http://dbpedia.org/property/h
|
27
|
| http://dbpedia.org/property/iupacName
|
Ethyl 4-morpholin-4-yl-2,2-dibutanoate
|
| http://dbpedia.org/property/legalAu
|
S9
|
| http://dbpedia.org/property/legalCa
|
Schedule I
|
| http://dbpedia.org/property/legalDe
|
Anlage I
|
| http://dbpedia.org/property/legalUs
|
Schedule I
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/pubchem
|
48194
|
| http://dbpedia.org/property/routesOfAdministration
|
Oral, Other ROA Unknown
|
| http://dbpedia.org/property/smiles
|
CCOCCc1ccccc1
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
LQGIXNQCOXNCRP-UHFFFAOYSA-N
|
| http://dbpedia.org/property/synonyms
|
Amidalgon, Spasmoxal
|
| http://dbpedia.org/property/unii
|
G751H98FY4
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
411018917
|
| http://dbpedia.org/property/width
|
180
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Opioidergics +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Analgesic-stub +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Mu-opioid_receptor_agonists +
, http://dbpedia.org/resource/Category:Butyrate_esters +
, http://dbpedia.org/resource/Category:Synthetic_opioids +
, http://dbpedia.org/resource/Category:Morpholines +
, http://dbpedia.org/resource/Category:Ethyl_esters +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Dioxaphetyl_butyrate?oldid=1082990781&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Spasmoxal.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Dioxaphetyl_butyrate +
|
| owl:sameAs |
http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB01475 +
, http://rdf.freebase.com/ns/m.03cp503 +
, http://sv.dbpedia.org/resource/Dioxafetylbutyrat +
, https://global.dbpedia.org/id/4j7Vt +
, http://sh.dbpedia.org/resource/Dioksafetil_butirat +
, http://hr.dbpedia.org/resource/Dioksafetil-butirat +
, http://sr.dbpedia.org/resource/Dioksafetil_butirat +
, http://dbpedia.org/resource/Dioxaphetyl_butyrate +
, http://yago-knowledge.org/resource/Dioxaphetyl_butyrate +
, http://www.wikidata.org/entity/Q5279649 +
, http://pl.dbpedia.org/resource/4-Morfolino-2%2C2-difenyloma%C5%9Blan_etylu +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Ester114850483 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/WikicatEthylEsters +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/WikicatCarboxylateEsters +
|
| rdfs:comment |
Dioxafetylbutyrat, summaformel C22H27NO3, … Dioxafetylbutyrat, summaformel C22H27NO3, är ett smärtstillande och kramplösande preparat som tillhör gruppen opioider. Preparatet används inte som läkemedel i Sverige. Substansen är narkotikaklassad och ingår i förteckningen N I i 1961 års allmänna narkotikakonvention, samt i förteckning II i Sverige.nvention, samt i förteckning II i Sverige.
, 4-Morfolino-2,2-difenylomaślan etylu – org … 4-Morfolino-2,2-difenylomaślan etylu – organiczny związek chemiczny, syntetyczny opioid objęty Jednolitą konwencją o środkach odurzających z 1961 roku (wykaz I) pod nazwą dioxaphetyl butyrate (maślan dioksafetylu). W Polsce znajduje się w kategorii I-N wykazu środków odurzających i substancji psychotropowych, zatem jego posiadanie jest nielegalne.ch, zatem jego posiadanie jest nielegalne.
, Dioxaphetyl butyrate (INN; trade names Ami … Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol. It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea. In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregate manufacturing quota of zero.ual aggregate manufacturing quota of zero.
|
| rdfs:label |
Dioxaphetyl butyrate
, Dioxafetylbutyrat
, 4-Morfolino-2,2-difenylomaślan etylu
|
